| Collaborations |
|
GENESIS Pharma SA
Joint Venture for Greece and the Balkans for OvaRex® MAb and other AltaRex antibody-based cancer therapeutics in development
|
|
Medison Pharma Ltd.
Joint Venture for Israel and the Middle East for OvaRex® MAb and other AltaRex antibody-based cancer therapeutics in development
|
|
Dompe Famaceutici S.p.A.
Strategic Business Alliance with Milan-based Dompe Farmaceutici for OvaRex® MAb for the territories of Italy, Spain, Portugal, Switzerland, Austria, and certain Eastern European countries. First offer for additional cancer antibodies in the territory.
|
|
FAES S.A.
Collaboration established June 2001. FAES becomes responsible for the marketing and sales of OvaRex® MAb for the territories of Spain and Portugal, via a sub-licensing agreement with Dompé and AltaRex.
|